M&T Bank
AERI

M&T Bank’s Aerie Pharmaceuticals AERI Stock Holding History

M&T Bank’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,132
Closed -$149K – 1637
2021
Q3 		$149K Buy
13,132
+534
+4% +$7.81K ﹤0.01% 1465
2021
Q2 		$202K Buy
12,598
+482
+4% +$8.27K ﹤0.01% 1466
2021
Q1 		$217K Buy
12,116
+1,317
+12% +$22.7K ﹤0.01% 1387
2020
Q4 		$146K Sell
10,799
-10,459
-49% -$126K ﹤0.01% 1558
2020
Q3 		$250K Buy
21,258
+1,309
+7% +$15.9K ﹤0.01% 1323
2020
Q2 		$295K Buy
19,949
+5,085
+34% +$75.2K ﹤0.01% 1195
2020
Q1 		$200K Buy
14,864
+5,235
+54% +$99.3K ﹤0.01% 1329
2019
Q4 		$233K Buy
+9,629
New +$199K ﹤0.01% 1201

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

M&T Bank's AERI Position: Q4 2021 in Review

M&T Bank sold out of Aerie Pharmaceuticals (AERI) in Q4 2021, closing a stake of 13,132 shares — an estimated $149K sold.

M&T Bank first reported a position in AERI in Q4 2019 and held it in 8 quarters. The position peaked at $295K in Q2 2020. 129 funds tracked by Wall St. Rank hold AERI as of Q4 2021.

  • M&T Bank reported no remaining Aerie Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • M&T Bank sold 13,132 Aerie Pharmaceuticals shares in Q4 2021, an estimated $149K.
  • M&T Bank first reported a position in Aerie Pharmaceuticals in Q4 2019 and held it in 8 quarters.
  • M&T Bank's Aerie Pharmaceuticals position peaked at $295K in Q2 2020.
  • 129 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2021.

Based on M&T Bank's 13F filing for Q4 2021, filed 7 Feb 2022.